Stay updated with breaking news from High Acuity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Amedisys (NASDAQ:AMED – Get Rating) was downgraded by stock analysts at Benchmark from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Tuesday, The Fly reports. Other analysts have also issued research reports about the company. SVB Securities decreased their price objective on Amedisys from $96.00 to […]
StockNews.com assumed coverage on shares of Amedisys (NASDAQ:AMED – Get Rating) in a report released on Saturday morning. The brokerage issued a buy rating on the health services provider’s stock. A number of other research firms have also recently commented on AMED. Barclays lowered their price objective on shares of Amedisys from $93.00 to $88.00 […]
StockNews.com began coverage on shares of Amedisys (NASDAQ:AMED – Get Rating) in a research report sent to investors on Saturday. The brokerage issued a buy rating on the health services provider’s stock. Several other research firms have also issued reports on AMED. Stephens reiterated an equal weight rating and issued a $103.00 target price on […]
Equities research analysts at StockNews.com started coverage on shares of Amedisys (NASDAQ:AMED – Get Rating) in a report released on Saturday. The firm set a “buy” rating on the health services provider’s stock. Several other analysts also recently commented on the stock. Truist Financial downgraded shares of Amedisys from a “buy” rating to a “hold” […]
Advantage Alpha Capital Partners LP lessened its holdings in shares of Amedisys, Inc. (NASDAQ:AMED – Get Rating) by 4.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 74,419 shares of the health services provider’s stock after selling 3,872 shares during the period. Amedisys […]